PRESS CONFERENCE: XMRV studies have attracted considerable press attention and this study — because of its definitive nature and the high profile of some of the investigators involved with it — is expected to generate media coverage. Columbia University’s Center for Infection and Immunity has scheduled a press conference for 10:30 a.m. (Eastern time) on Sept. 18, 2012, featuring Dr. Lipkin and four of the key collaborators on the study:
Dr. Harvey Alter of the National Institutes of Health,
Dr. Judy Mikovits who is now working independently,
Dr. Francis Ruscetti of the National Cancer Institute,
William Switzer of the U.S. Centers for Disease Control & Prevention and
Dr. Mady Hornig of the Center for Infection and Immunity at Columbia University. The press conference will be webcast live. Details about and the URL for accessing the press conference at that time can be found here:
http://cii.yewda.com/Blog.aspx?LOfRcb